{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:30:51Z","timestamp":1791804651498,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019776","name":"European University of Madrid","doi-asserted-by":"publisher","award":["2020\/UEM01"],"award-info":[{"award-number":["2020\/UEM01"]}],"id":[{"id":"10.13039\/100019776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.brachy.2024.02.009","type":"journal-article","created":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T20:30:07Z","timestamp":1711225807000},"page":"342-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8453-5971","authenticated-orcid":false,"given":"Ana Aurora","family":"D\u00edaz-Gavela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia del","family":"Cerro Pe\u00f1alver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Sanchez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Pardo-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel John","family":"Thuissard-Vasallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7558-4325","authenticated-orcid":false,"given":"Cristina","family":"Andreu-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Yolanda","family":"Molina L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pena Huertas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Leonardo","family":"Guerrero-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sanz-Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Counago","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2024.02.009_bib0001","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2024.02.009_bib0002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","article-title":"Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial","volume":"16","author":"Bartelink","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0003","article-title":"Tumour bed boost radiotherapy for women after breast-conserving surgery","volume":"11","author":"Kindts","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.brachy.2024.02.009_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.753209","article-title":"Comparing hypofractionated with conventional fractionated radiotherapy after breast-conserving surgery for early breast cancer: a meta-analysis of randomized controlled trials","volume":"11","author":"Gu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0005","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clon.2020.12.008","article-title":"The financial impact on reimbursement of moderately hypofractionated postoperative radiation therapy for breast cancer: an International Consortium report","volume":"33","author":"Marta","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.brachy.2024.02.009_bib0006","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000489638","article-title":"The role of brachytherapy in the treatment of breast cancer","volume":"13","author":"Kauer-Dorner","year":"2018","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.brachy.2024.02.009_bib0007","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijrobp.2014.09.024","article-title":"High-dose-rate brachytherapy boost effect on local tumor control in young women with breast cancer","volume":"91","author":"Guinot","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.02.009_bib0008","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.3390\/cancers14102564","article-title":"The role of interstitial brachytherapy for breast cancer treatment: an overview of indications, applications, and technical notes","volume":"14","author":"Cozzi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.brachy.2024.02.009_bib0009","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2016.06.014","article-title":"10-Year follow-up of 621 patients treated using high-dose rate brachytherapy as ambulatory boost technique in conservative breast cancer treatment","volume":"122","author":"Qu\u00e9ro","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0010","series-title":"StatPearls","article-title":"WHO analgesic ladder","author":"Anekar","year":"2023"},{"issue":"15_Suppl","key":"10.1016\/j.brachy.2024.02.009_bib0011","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1200\/JCO.2018.36.15_suppl.560","article-title":"Hypofractionated whole breast IMRT and brachytherapy boost after conservative surgery for breast cancer: early results of a prospective non-randomised trial","volume":"36","author":"Guix","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0012","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brachy.2024.02.009_bib0013","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1200\/JCO.20.01024","article-title":"Hypofractionated versus conventional fractionated radiotherapy after breast-conserving surgery in the modern treatment era: a multicenter, randomized controlled trial from China","volume":"38","author":"Wang","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0014","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0015","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: the DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0016","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1470-2045(06)70699-4","article-title":"Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial","volume":"7","author":"Owen","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0017","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1200\/JCO.2007.11.4991","article-title":"Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial","volume":"25","author":"Bartelink","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0018","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s12094-012-0881-4","article-title":"Conservative surgery, external radiotherapy, and HDR brachytherapy in a single fraction of 7 Gy in early breast cancer: long-term toxicity and esthetic assessment","volume":"14","author":"Rodr\u00edguez P\u00e9rez","year":"2012","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0019","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0167-8140(02)00022-1","article-title":"Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR\/HDR) for T1\/T2 breast cancer","volume":"63","author":"Resch","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00066-002-1053-1","article-title":"Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial","volume":"178","author":"Polg\u00e1r","year":"2002","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0021","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ijrobp.2008.02.007","article-title":"Tumor location, interval between surgery and radiotherapy, and boost technique influence local control after breast-conserving surgery and radiation: retrospective analysis of monoinstitutional long-term results","volume":"72","author":"Knauerhase","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.02.009_bib0022","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/annonc\/mds066","article-title":"Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC \u201cboost versus no boost\u201d trial","volume":"23","author":"Immink","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0023","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.ejca.2008.07.032","article-title":"Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC trial 22881-10882 'boost versus no boost'","volume":"44","author":"Collette","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.brachy.2024.02.009_bib0024","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0360-3016(94)90312-3","article-title":"Dose and volume effects on fibrosis after breast conservation therapy","volume":"30","author":"Borger","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.02.009_bib0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1507-1367(05)71083-X","article-title":"Does interstitial HDR brachytherapy for breast cancer increase soft tissue fibrosis?","volume":"10","author":"Wronczewska","year":"2005","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.brachy.2024.02.009_bib0026","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.radonc.2018.04.009","article-title":"ESTRO-ACROP guideline: interstitial multi-catheter breast brachytherapy as accelerated partial breast irradiation alone or as boost\u2014GEC-ESTRO Breast Cancer Working Group practical recommendations","volume":"128","author":"Strnad","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0027","doi-asserted-by":"crossref","first-page":"P2124","DOI":"10.1016\/S0140-6736(23)00619-0","article-title":"Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial","volume":"401","author":"Coles","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2024.02.009_bib0028","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamaoncol.2015.2590","article-title":"Differences in the acute toxic effects of breast radiotherapy by fractionation schedule: comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohort","volume":"1","author":"Jagsi","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0029","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.ijrobp.2012.01.069","article-title":"Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast cancer: the Fox Chase Cancer Center experience","volume":"84","author":"Keller","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.02.009_bib0030","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1120\/jacmp.v12i2.3451","article-title":"Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When?","volume":"12","author":"Morganti","year":"2011","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.brachy.2024.02.009_bib0031","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1200\/JCO.2013.49.7842","article-title":"Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis","volume":"31","author":"Mukesh","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0032","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2147\/OTT.S127833","article-title":"Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial","volume":"10","author":"Lazzari","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.brachy.2024.02.009_bib0033","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/030089160909500323","article-title":"Prone breast radiotherapy in a patient with early stage breast cancer and a large pendulous breast","volume":"95","author":"Ferrari","year":"2009","journal-title":"Tumori"},{"key":"10.1016\/j.brachy.2024.02.009_bib0034","first-page":"143","article-title":"Hypofractionated radiotherapy after conservative surgery may increase low-intermediate grade late fibrosis in breast cancer patients","volume":"10","author":"Diges\u00f9","year":"2018","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.brachy.2024.02.009_bib0035","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ijrobp.2012.01.093","article-title":"Hypofractionated whole-breast radiation therapy: does breast size matter?","volume":"84","author":"Hannan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.02.009_bib0036","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6745954","article-title":"Factors associated with late local radiation toxicity after post-operative breast irradiation","volume":"2022","author":"Batenburg","year":"2022","journal-title":"Breast J"},{"key":"10.1016\/j.brachy.2024.02.009_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.753209","article-title":"Comparing hypofractionated with conventional fractionated radiotherapy after breast-conserving surgery for early breast cancer: a meta-analysis of randomized controlled trials","volume":"11","author":"Gu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0038","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.adro.2018.10.005","article-title":"The effect of breast volume on toxicity using hypofractionated regimens for early stage breast cancer for patients","volume":"4","author":"Butler-Xu","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0039","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2004.03.007","article-title":"The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial","volume":"72","author":"Poortmans","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0040","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1200\/JCO.2008.21.7075","article-title":"Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel","volume":"27","author":"Millar","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0041","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12609-020-00384-x","article-title":"Accelerated partial breast irradiation (APBI): where are we now?","volume":"12","author":"Goldberg","year":"2020","journal-title":"Curr Breast Cancer Rep"},{"key":"10.1016\/j.brachy.2024.02.009_bib0042","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1470-2045(23)00018-9","article-title":"Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial","volume":"24","author":"Strnad","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2024.02.009_bib0043","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2024.02.009_bib0044","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2207586","article-title":"Breast-conserving surgery with or without irradiation in early breast cancer","volume":"388","author":"Kunkler","year":"2023","journal-title":"N Engl J Med"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124000412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124000412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T14:33:07Z","timestamp":1715697187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472124000412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1538472124000412"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2024.02.009","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2024.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}